San Diego, CA, United States of America

Mehrnouch Motamedi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mehrnouch Motamedi: Innovator in Pharmaceutical Modulation

Introduction

Mehrnouch Motamedi is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate androgen and progesterone receptors. His work is essential for advancing therapeutic options in various medical conditions.

Latest Patents

Motamedi holds a patent for "Bicyclic androgen and progesterone receptor modulator compounds and methods." This invention focuses on nonsteroidal compounds and compositions that act as high-affinity, high-specificity agonists, partial agonists, and antagonists for androgen and progesterone receptors. The patent outlines methods for synthesizing these compounds and their pharmaceutical compositions, which are crucial for modulating processes mediated by these receptors.

Career Highlights

Currently, Mehrnouch Motamedi is associated with Ligand Pharmaceuticals, Inc. His role at the company allows him to leverage his expertise in pharmaceutical development and innovation. With a patent portfolio that includes 1 patent, he continues to contribute to the advancement of medical science.

Collaborations

Motamedi has worked alongside talented colleagues such as Lin Zhi and Christopher Michael Tegley. Their collaborative efforts enhance the research and development processes within their field.

Conclusion

In summary, Mehrnouch Motamedi is a distinguished inventor whose work in pharmaceutical modulation has the potential to impact medical treatments significantly. His innovative approaches and collaborations continue to drive advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…